Reinhard Edmund Voll
#163,653
Most Influential Person Now
Reinhard Edmund Voll's AcademicInfluence.com Rankings
Reinhard Edmund Vollbiology Degrees
Biology
#13114
World Rank
#16641
Historical Rank
Immunology
#895
World Rank
#918
Historical Rank

Download Badge
Biology
Reinhard Edmund Voll's Degrees
- PhD Immunology Stanford University
- Doctorate Medicine Stanford University
Why Is Reinhard Edmund Voll Influential?
(Suggest an Edit or Addition)Reinhard Edmund Voll's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Immunosuppressive effects of apoptotic cells (1997) (1866)
- Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. (1998) (1282)
- Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis (2010) (1194)
- Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. (1998) (880)
- A rapid and simple method for the isolation of apoptotic DNA fragments. (1994) (677)
- Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. (2002) (563)
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis (2008) (543)
- Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE (2008) (525)
- Release of High Mobility Group Box 1 by Dendritic Cells Controls T Cell Activation via the Receptor for Advanced Glycation End Products1 (2005) (524)
- Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition. (2007) (388)
- NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. (2000) (300)
- Clearance deficiency and systemic lupus erythematosus (SLE). (2007) (294)
- The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus (2015) (281)
- Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus (2016) (235)
- Impaired clearance of dying cells in systemic lupus erythematosus. (2005) (222)
- SLE--a disease of clearance deficiency? (2005) (215)
- Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum (2006) (212)
- 12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance (2011) (210)
- Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients. (2009) (185)
- Clearance of apoptotic cells in human SLE. (2006) (176)
- Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation. (2000) (175)
- Factors masking HMGB1 in human serum and plasma (2007) (170)
- Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death (2001) (165)
- Inhibition of Phosphatidylserine Recognition Heightens the Immunogenicity of Irradiated Lymphoma Cells In Vivo (2004) (165)
- Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. (2003) (162)
- Sodium Overload and Water Influx Activate the NALP3 Inflammasome (2010) (157)
- Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. (1997) (151)
- T Cell Costimulation Molecules CD80/86 Inhibit Osteoclast Differentiation by Inducing the IDO/Tryptophan Pathway (2014) (146)
- 12/15-Lipoxygenase Counteracts Inflammation and Tissue Damage in Arthritis (2009) (144)
- Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. (2009) (122)
- Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis (2011) (121)
- How antirheumatic drugs protect joints from damage in rheumatoid arthritis. (2008) (119)
- Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides (2012) (117)
- Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin. (2004) (117)
- Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation. (2010) (103)
- Anti-inflammatory effect of low-dose X-irradiation and the involvement of a TGF-β 1 -induced down-regulation of leukocyte/endothelial cell adhesion (2002) (100)
- Inhibition of NF-κB Activity and Enhancement of Apoptosis by the Neuropeptide Calcitonin Gene-related Peptide* (2000) (94)
- Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players (2010) (93)
- A Subclass of Ras Proteins That Regulate the Degradation of IκB (2000) (93)
- Inefficient clearance of dying cells and autoreactivity. (2006) (92)
- Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) (2013) (89)
- Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course (2019) (89)
- Involvement of phosphatidylserine, αvβ3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages (2006) (87)
- DNA Damage Signaling Instructs Polyploid Macrophage Fate in Granulomas (2016) (83)
- Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice (2000) (80)
- Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus (2010) (79)
- Viable, apoptotic and necrotic monocytes expose phosphatidylserine: cooperative binding of the ligand Annexin V to dying but not viable cells and implications for PS-dependent clearance (2005) (79)
- Pathogenesis of autoimmunity in common variable immunodeficiency (2012) (73)
- Apoptosis and systemic lupus erythematosus. (2004) (72)
- NF-κB inhibitor targeted to activated endothelium demonstrates a critical role of endothelial NF-κB in immune-mediated diseases (2013) (72)
- B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients (2017) (70)
- Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases (2021) (67)
- Helix-loop-helix proteins regulate pre-TCR and TCR signaling through modulation of Rel/NF-kappaB activities. (2002) (66)
- After shrinkage apoptotic cells expose internal membrane-derived epitopes on their plasma membranes (2008) (65)
- Successful treatment of extensive calcifications and acute pulmonary involvement in dermatomyositis with the Janus-Kinase inhibitor tofacitinib - A report of two cases. (2019) (63)
- High frequency of autoantibody‐secreting cells and long‐lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice (2011) (62)
- Proteasome inhibition drastically but reversibly impairs murine lymphocyte development (2008) (60)
- Lectins detect changes of the glycosylation status of plasma membrane constituents during late apoptosis (2006) (59)
- Differential role of the transcription factor NF-kappaB in selection and survival of CD4+ and CD8+ thymocytes. (2008) (59)
- Involvement of phosphatidylserine, alphavbeta3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages. (2006) (57)
- Dose‐dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF‐κB) in EA.hy.926 endothelial cells after low‐dose X‐irradiation (2004) (55)
- Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis. (2017) (54)
- High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases. (2008) (54)
- Siglec-G Regulates B1 Cell Survival and Selection (2010) (54)
- Circulating chromogranin A reveals extra‐articular involvement in patients with rheumatoid arthritis and curbs TNF‐α‐elicited endothelial activation (2008) (54)
- Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis (2009) (52)
- Bone‐ and Cartilage‐Protective Effects of a Monoclonal Antibody Against Colony‐Stimulating Factor 1 Receptor in Experimental Arthritis (2014) (52)
- Abatacept modulates CD80 and CD86 expression and memory formation in human B-cells. (2019) (52)
- Exposure of anionic phospholipids serves as anti-inflammatory and immunosuppressive signal--implications for antiphospholipid syndrome and systemic lupus erythematosus. (2003) (51)
- Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat. (2010) (49)
- Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus. (2013) (49)
- The protein tyrosine phosphatase PTP1B is a negative regulator of CD40 and BAFF-R signaling and controls B cell autoimmunity (2014) (47)
- Sensitive detection of plasma/serum DNA in patients with systemic lupus erythematosus (2007) (47)
- The Induction of TGF-β1 and NF-κB Parallels a Biphasic Time Course of Leukocyte/Endothelial Cell Adhesion Following Low-Dose X-Irradiation (2004) (47)
- Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study (2012) (46)
- A subclass of Ras proteins that regulate the degradation of IkappaB. (2000) (45)
- Defects in the disposal of dying cells lead to autoimmunity (2004) (45)
- The expansion of human T-bethighCD21low B cells is T cell dependent (2021) (44)
- Early detection of apoptosis by staining of acid‐treated apoptotic cells with FITC‐labeled lectin from Narcissus pseudonarcissus (2003) (43)
- The Proteasome Inhibitor Bortezomib Prevents Lupus Nephritis in the NZB/W F1 Mouse Model by Preservation of Glomerular and Tubulointerstitial Architecture (2012) (43)
- Do We Need New Treatment That Goes beyond Tumor Necrosis Factor Blockers for Rheumatoid Arthritis? (2005) (42)
- Activation of NF-kappaB promotes the transition of large, CD43+ pre-B cells to small, CD43- pre-B cells. (2005) (42)
- Discontinuous induction of X-linked inhibitor of apoptosis in EA.hy.926 endothelial cells is linked to NF-κB activation and mediates the anti-inflammatory properties of low-dose ionising-radiation. (2010) (42)
- National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD (2020) (41)
- Calcium Channel Blocker Verapamil Enhances Reticulum Stress and Death Induced by Proteasome Inhibition in Myeloma Cells (2010) (40)
- Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency (2016) (40)
- What triggers anti-dsDNA antibodies? (2004) (40)
- Impact of tofacitinib treatment on human B-cells in vitro and in vivo. (2017) (39)
- Inhibition of NF-kappaB activity and enhancement of apoptosis by the neuropeptide calcitonin gene-related peptide. (2000) (39)
- Disposal of dying cells: a balancing act between infection and autoimmunity. (2003) (38)
- Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis (2016) (37)
- Reconstitution of the peripheral B lymphocyte compartment in patients with ANCA-associated vasculitides treated with rituximab for relapsing or refractory disease (2014) (36)
- Hydrostatic pressure induced death of mammalian cells engages pathways related to apoptosis or necrosis. (2004) (35)
- UV irradiation inhibits ABC transporters via generation of ADP-ribose by concerted action of poly(ADP-ribose) polymerase-1 and glycohydrolase (2004) (34)
- Calcium channel blocker verapamil enhances endoplasmic reticulum stress and cell death induced by proteasome inhibition in myeloma cells. (2010) (34)
- CD20 as a gatekeeper of the resting state of human B cells (2020) (33)
- Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus (2010) (33)
- Removal of dying cells and systemic lupus erythematosus (2005) (33)
- The induction of TGF-beta(1) and NF-kappaB parallels a biphasic time course of leukocyte/endothelial cell adhesion following low-dose X-irradiation. (2004) (32)
- Loading of nuclear autoantigens prototypically recognized by systemic lupus erythematosus sera into late apoptotic vesicles requires intact microtubules and myosin light chain kinase activity (2015) (32)
- IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera (2007) (31)
- Microparticles Shed from Different Antigen‐Presenting Cells Display an Individual Pattern of Surface Molecules and a Distinct Potential of Allogeneic T‐Cell Activation (2005) (30)
- HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis (2015) (29)
- Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance (2022) (29)
- Impaired clearance of apoptotic cells in systemic lupus erythematosus: Challenge of T and B cell tolerance (2003) (29)
- Vegan diet reduces neutrophils, monocytes and platelets related to branched-chain amino acids - A randomized, controlled trial. (2020) (28)
- Detection of restricted junctional diversity of peripheral T cells in SLE patients by spectratyping (1997) (28)
- Composition of clogging material in pancreatic endoprostheses. (2005) (28)
- Serum Levels of HMGB1 in Postmenopausal Patients with Rheumatoid Arthritis: Associations with Proinflammatory Cytokines, Acute-phase Reactants, and Clinical Disease Characteristics (2011) (28)
- Whipple’s disease mimicking rheumatoid arthritis can cause misdiagnosis and treatment failure (2017) (27)
- Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells. (2012) (27)
- Methylation-dependent activation of CDX1 through NF-κB: a link from inflammation to intestinal metaplasia in the human stomach. (2012) (27)
- Arterial and venular endothelial cell costimulation of cytokine secretion by human T cell clones (1998) (26)
- Cell-Intrinsic NF-κB Activation Is Critical for the Development of Natural Regulatory T Cells in Mice (2011) (26)
- Soluble human CD83 ameliorates lupus in NZB/W F1 mice. (2013) (26)
- After shrinkage apoptotic cells expose internal membrane-derived epitopes on their plasma membranes (2007) (26)
- FcgammaRIIa genotype is associated with acute coronary syndromes as first manifestation of coronary artery disease. (2009) (25)
- Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases (2020) (25)
- Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma (2018) (25)
- Interaction of histones with phospholipids—implications for the exposure of histones on apoptotic cells (2007) (24)
- Loss of GM1 surface expression precedes annexin V‐phycoerythrin binding of neutrophils undergoing spontaneous apoptosis during in vitro aging (2004) (24)
- Activator protein 1 shows a biphasic induction and transcriptional activity after low dose X-irradiation in EA.hy.926 endothelial cells (2009) (23)
- Triggering of NF‐κB in cytokine‐matured human DCs generates superior DCs for T‐cell priming in cancer immunotherapy (2014) (23)
- Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study (2021) (23)
- Ex vivo– and in vivo–induced dead tumor cells as modulators of antitumor responses (2010) (22)
- Apoptotic cells selectively suppress the Th1 cytokine interferon γ in stimulated human peripheral blood mononuclear cells and shift the Th1/Th2 balance towards Th2 (2007) (22)
- Naive- and Memory-like CD21low B Cell Subsets Share Core Phenotypic and Signaling Characteristics in Systemic Autoimmune Disorders (2020) (21)
- Amelioration of type II collagen induced arthritis in rats by treatment with sodium diethyldithiocarbamate. (1999) (20)
- CD4 positive peripheral T cells from patients with systemic lupus erythematosus (SLE) are clonally expanded (2001) (20)
- Low Dietary Fiber Intake Links Development of Obesity and Lupus Pathogenesis (2021) (19)
- The Antigen Presenting Potential of CD21low B Cells (2020) (19)
- B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides (2013) (18)
- High Levels of SOX5 Decrease Proliferative Capacity of Human B Cells, but Permit Plasmablast Differentiation (2014) (18)
- Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis. (2011) (18)
- Modulation of granulocyte-endothelium interactions by antileukoproteinase: inhibition of anti-type II collagen antibody-induced leukocyte attachment to the synovial endothelium (2006) (17)
- Renal uptake of the antiapoptotic protein survivin is mediated by megalin at the apical membrane of the proximal tubule. (2013) (17)
- Soluble CD90 as a potential marker of pulmonary involvement in systemic sclerosis (2013) (17)
- Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting (2018) (16)
- Patterns of fatigue and association with disease activity and clinical manifestations in systemic lupus erythematosus. (2020) (16)
- TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD (2021) (15)
- The Early Marginal Zone B Cell-Initiated T-Independent Type 2 Response Resists the Proteasome Inhibitor Bortezomib (2010) (15)
- Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination (2017) (15)
- A new regulatory mechanism of NF-kappaB activation by I-kappaBbeta in cancer cells. (2008) (15)
- A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE (2020) (14)
- The role of high-mobility group box 1 protein in the pathogenesis of autoimmune diseases (2008) (13)
- The CFSE Distribution Assay is a Powerful Technique for the Analysis of Radiation–Induced Cell Death and Survival on a Single–Cell Level (2005) (13)
- [IL-1-blockade with Anakinra during pregnancy : Retrospective analysis of efficacy and safety in female patients with familial Mediterranean fever]. (2018) (12)
- Coagulation activation and fluid retention associated with the use of black cohosh: a case study (2010) (12)
- COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis (2020) (12)
- Bronchoalveolar lavage cytology resembles sarcoidosis in a subgroup of granulomatous CVID (2014) (12)
- NF-κB activation triggers NK-cell stimulation by monocyte-derived dendritic cells (2019) (12)
- Staphylococcus aureus bacteremia in patients with rheumatoid arthritis - Data from the prospective INSTINCT cohort. (2017) (12)
- Long-Term Partial Remission of AutoImmune Thrombocytopenia in a Patient Treated with the Anti-Tumor Necrosis Factor-Alpha Antibody Infliximab for Refractory Fistulizing Crohn’s Disease (2008) (12)
- Plasmacytoid dendritic cell activation is dependent on coordinated expression of distinct amino acid transporters. (2021) (12)
- CCL18 — Potential Biomarker of Fibroinflammatory Activity in Chronic Periaortitis (2012) (12)
- CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1 (2021) (11)
- Dual Role of Interleukin-10 in Murine NZB/W F1 Lupus (2021) (11)
- Serological lymphocytic activity and patient-reported outcomes in Sjögren’s syndrome (2018) (11)
- Patients with unstable angina pectoris show an increased frequency of the Fc gamma RIIa R131 allele (2012) (11)
- DNA Damage Signaling Instructs Polyploid Macrophage Fate in Granulomas (2018) (10)
- Signals, receptors, and cytokines involved in the immunomodulatory and anti-inflammatory properties of apoptotic cells (2005) (9)
- A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol (2021) (9)
- Inflammatory stays inflammatory: a subgroup of systemic sclerosis characterized by high morbidity and inflammatory resistance to cyclophosphamide (2019) (9)
- Hypothesis: human serum-borne albumin bound lipids promote cellular survival after apoptosis induction by a variety of stimuli (2008) (9)
- Sneaking-ligand fusion proteins attenuate serum transfer arthritis by endothelium-targeted NF-κB inhibition. (2015) (8)
- Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations (2020) (8)
- Peripheral Blood Stem Cells of Patients with Systemic Lupus Erythematosus Show Altered Differentiation into Macrophages (2010) (8)
- Therapeutic inhibition of proteasomes in systemic lupus erythematosus (2011) (7)
- Circulating multimeric immune complexes drive immunopathology in COVID-19 (2021) (7)
- Association of High Mobility Group Box Chromosomal Protein 1 and Receptor for Advanced Glycation End Products Serum Concentrations With Extraglandular Involvement and Disease Activity in Sjögren's Syndrome (2018) (7)
- A multicenter blinded preclinical randomized controlled trial on Jak1/2 inhibition in MRL/MpJ-Faslpr mice with proliferative lupus nephritis predicts low effect size. (2021) (7)
- Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies. (2022) (7)
- Do low vitamin D levels cause problems of waste removal in patients with SLE? (2012) (7)
- The role of a defective clearance in the pathogenesis of systemic lupus erythematosus (2004) (7)
- Apoptosis of the Teratocarcinoma Cell Line Tera‐1 Leads to the Cleavage of HERV‐K10gag Proteins by Caspases and/or Granzyme B (2002) (7)
- Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis? (2021) (7)
- Elevated serum osteopontin levels in idiopathic retroperitoneal fibrosis. (2012) (7)
- Role of NF-kappa B in T-lymphocyte development. (1999) (7)
- IgG4-related disease in autoimmune lymphoproliferative syndrome. (2017) (6)
- Blastic CD56+ natural killer-cell lymphoma with primary cutaneous manifestation. (2003) (6)
- Cell Survival Failure in Effector T Cells From Patients With Systemic Lupus Erythematosus Following Insufficient Up‐Regulation of Cold‐Shock Y‐Box Binding Protein 1 (2020) (5)
- Inhibition of NF- k B Activity and Enhancement of Apoptosis by the Neuropeptide Calcitonin Gene-related Peptide* (2000) (5)
- [Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination]. (2021) (5)
- Non permissive bone marrow environment impairs early B-cell development in common variable immunodeficiency. (2020) (5)
- Optimized isolation of renal plasma cells for flow cytometric analysis. (2019) (5)
- [Plasma cells]. (2015) (5)
- The "sneaking-ligand" approach: cell-type specific inhibition of the classical NF-κB pathway. (2015) (5)
- The low-throughput protein A adsorber: an immune modulatory device. Hypothesis for the mechanism of action in the treatment of rheumatoid arthritis (2005) (5)
- Retinal Vessel Diameters and Physical Activity in Patients With Mild to Moderate Rheumatic Disease Without Cardiovascular Comorbidities (2018) (5)
- [Depletion of plasma cells - a novel strategy in the therapy of systemic lupus erythematosus in mice and man]. (2009) (5)
- Selective silencing of autoreactive B lymphocytes-Following the Nature's way. (2010) (5)
- Swimming against the stream: the fishbowl discussion method as an interactive tool for medical conferences: experiences from the 11th European Lupus Meeting (2018) (5)
- Neuraminidase Inhibitor Zanamivir Ameliorates Collagen-Induced Arthritis (2021) (4)
- Possible misclassification of cardiovascular risk by SCORE in antisynthetase syndrome: results of the pilot multicenter study RI.CAR.D.A. (2020) (4)
- A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants (2021) (4)
- Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel (2021) (4)
- [The role of incomplete clearance of apoptotic cells in the etiology and pathogenesis of SLE]. (2010) (4)
- Low-Salt Diet Attenuates B-Cell- and Myeloid-Cell-Driven Experimental Arthritides by Affecting Innate as Well as Adaptive Immune Mechanisms (2021) (3)
- Targeted silencing of DNA‐specific B cells combined with partial plasma cell depletion displays additive effects on delaying disease onset in lupus‐prone mice (2013) (3)
- Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination (2021) (3)
- Failure of upregulation of the cold shock Y-box protein-1 in effector T-cells of systemic lupus erythematosus patients averts cell survival. (2020) (3)
- A survey to evaluate knowledge, perceptions and attitudes toward COVID-19 vaccinations among rheumatologists in Germany (2021) (3)
- Circulating mitochondrial DNA copy numbers represent a sensitive marker for diagnosis and monitoring of disease activity in systemic lupus erythematosus (2021) (3)
- Social class, social mobility and status differences in marriage: Relevant for child psychiatry? (2004) (3)
- Polymorphisms in the Hsp 70 gene locus are genetically associated with systemic lupus erythematosus (2010) (3)
- Relevance of Receptor for Advanced Glycation end Products (RAGE) in Murine Antibody-Mediated Autoimmune Diseases (2019) (3)
- [Off-label biologic therapy of ANCA-associated and non-ANCA-associated small-vessel vasculitis : Efficacy and safety analysis of a national registry (GRAID2)]. (2018) (3)
- Small DNA fragments isolated from human T-cell clones are enriched in sequences involved in DNA bending. (1996) (3)
- CO0004 OLDER AGE, CARDIOVASCULAR COMORBIDITY AND GLUCOCORTICOSTEROIDS ARE RISK FACTORS FOR COVID-19 HOSPITALISATION IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: FIRST RESULTS OF THE GERMAN COVID-19-IRD REGISTRY (2020) (3)
- Case Report: Effective and Safe Treatment With Certolizumab Pegol in Pregnant Patients With Cogan’s Syndrome: A Report of Three Pregnancies in Two Patients (2021) (3)
- Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry (2022) (3)
- [Vaccinations in rheumatology]. (2010) (3)
- The MRZ-Reaction and Specific Autoantibody Detection for Differentiation of ANA-Positive Multiple Sclerosis From Rheumatic Diseases With Cerebral Involvement (2019) (3)
- Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study (2020) (2)
- CVID-Associated B Cell Activating Factor Receptor Variants Change Receptor Oligomerization, Ligand Binding, and Signaling Responses (2021) (2)
- Circulating multimeric immune complexes contribute to immunopathology in COVID-19 (2022) (2)
- Clinical images: Multilocular tenosynovitis as a manifestation of sarcoidosis. (2012) (2)
- [Prospective multicenter observational study of early rheumatoid arthritis--prognostic factors and predictors of disease course]. (2000) (2)
- [Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)]. (2018) (2)
- Immune complexes as culprits of immunopathology in severe COVID-19 (2022) (2)
- Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022 (2023) (2)
- A non-peptide AT2 receptor agonist attenuates clinical and histological signs in murine collagen-induced arthritis (2012) (2)
- A marriage with sarcoidosis (2013) (2)
- Immune complex solubility and size govern Fc-gamma receptor responses: A scalable cell-based reporter system (2020) (2)
- Interferon Lambda Regulates Cellular and Humoral Immunity in Pristane-Induced Lupus (2021) (2)
- Sleep apnea in Sjögren’s syndrome potentially influences the EULAR Sjögren’s syndrome patient reported index (2018) (2)
- [Lupus erythematosus - Update 2016]. (2016) (2)
- Abatacept retention and clinical outcomes in rheumatoid arthritis: real-world data from the German cohort of the ACTION study and a comparison with other participating countries (2019) (2)
- Angiotensin AT2 Receptor Stimulation Alleviates Collagen-Induced Arthritis by Upregulation of Regulatory T Cell Numbers (2022) (2)
- Spuriously low IgG levels in lupus-associated mixed cryoglobulinaemia type II complicated by iatrogenic immunoglobulin-induced immune complex vasculitis. (2012) (2)
- High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection (2022) (2)
- Anti‐Inflammatory and Immunoregulatory Effects of Apoptotic Cells (2004) (2)
- The sneaking ligand approach for cell type-specific modulation of intracellular signalling pathways. (2017) (2)
- [Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany]. (2020) (2)
- P55 Influence of dietary fibre and short-chain fatty acids on the pathogenesis of systemic lupus erythematosus (2020) (2)
- BAFFR activates PI3K/AKT signaling in human naive but not in switched memory B cells through direct interactions with B cell antigen receptors. (2022) (2)
- Involvement of toll-like receptor 2 in pristane-induced lupus (2011) (2)
- 12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunological tolerance (2011) (1)
- Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells (2010) (1)
- A Tissue-specific NF-κB inhibitor ameliorates inflammatory joint diseases (2010) (1)
- Introduction: B cell-mediated autoimmune diseases (2014) (1)
- Novel treatment strategies for antibody-mediated diseases: targeting long-lived plasma cells (2008) (1)
- Abstract 406: Direct Angiotensin AT2-Receptor Stimulation Modifies T-Cell Differentiation (2014) (1)
- Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial (2023) (1)
- HMGB1 containing nucleosomes from apoptotic cells induce inflammation and immune activation via TLR2 – implications for the etiopathogenesis of systemic lupus erythematosus (2010) (1)
- Rheumatoid factor IgM autoantibodies control IgG homeostasis (2022) (1)
- Correspondence to ‘Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases’ (2020) (1)
- SAT0177 12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance (2013) (1)
- POS1261 DISEASE ACTIVITY AND PAIN LEVELS ARE NOT INFLUENCED BY THE CURRENT COVID19 PANDEMIC IN PATIENTS WITH RHEUMATIC DISEASES IN GERMANY – DATA FROM THE GERMAN COVID-19 PATIENT SURVEY (2021) (1)
- AB0593 Predictors of fatigue and severe fatigue in a large multicenter international cohort of patients with systemic lupus erythematosus: the fatilup study (2018) (1)
- OP0283 DOES TNF-INHIBITION DECREASE THE RISK OF SEVERE COVID-19 IN RMD-PATIENTS? (2021) (1)
- Exosomes Secreted By Multiple Myeloma Cell Lines (MMCLs) and Bone Marrow Stromal Cells (BMSCs) Reciprocally Modulate Cell Adhesion and Impact on MM Cell Migration and Bortezomib-Induced Apoptosis (2014) (1)
- [Television watching, reading habits and psychiatric disorders in 8-year-old children]. (1983) (1)
- Dose-dependent biphasic expression of nuclear factor KappaB (NF-κB) in endothelial cells by low-dose ionizing radiation (2001) (1)
- Lupus erythematodes – Update 2016 (2016) (1)
- Detection and functional resolution of soluble multimeric immune complexes (2021) (1)
- Apoptosis and Necrosis of Mammalian Cells after High Pressure Treatment — Prospects for a Tumor Vaccine (2003) (1)
- New bortezomib-based combination therapy for elimination of myeloma cells (2009) (1)
- Autoantibody secreting cells and long-lived plasma cells are enriched within inflamed kidneys of NZB/NZW F1 lupus mice and sensitive to bortezomib treatment (2011) (1)
- The Low Throughput Protein A Adsorber: An Immune Modulatory Device for the Treatment of Rheumatoid Arthritis (2007) (1)
- 7.3 Akute Pyelonephritis (2013) (0)
- 5.3 Reizdarmsyndrom (RDS) (2013) (0)
- THU0029 Ctla-4-ig treatment induces modulation of b-cell function and differentiation (2018) (0)
- 2.9 Invasive Methoden (2013) (0)
- AB0033 CHARACTERIZATION OF THE PERIPHERAL B CELL COMPARTMENT IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (2020) (0)
- 3.6 Zyanose (2013) (0)
- Medicine, particularly for modulating the immune response den fighting viruses, tumors, bacteria and parasites. (1996) (0)
- Zellstress-assoziierte Expression von High Mobility Group Box (HMGB)-1 und dessen Receptor for Advanced Glycation Endproducts (RAGE) im Skelettmuskel der sporadischen Einschlusskörperchenmyositis (sIBM) (2008) (0)
- THU0379 DEPRESSIVE SYMPTOMS AND FUNCTIONAL IMPAIRMENT ARE FREQUENT AND AFFECT QUALITY OF LIFE IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS: A QUESTIONNAIRE-BASED ASSESSMENT OF 300 PATIENTS COMPARED WITH 150 PATIENTS WITH PSORIASIS AND 150 PATIENTS WITH MECHANICAL BACK PAIN (2019) (0)
- manipulated dendritic cells in its path signal transmission NFkB (2011) (0)
- FRI0311 The effect of b cell targeted therapies on autoantibodies and excessive neutrophil extracellular trap formation in systemic lupus erythematosus patients (2018) (0)
- CD56+-NK-Zell-Lymphome (2003) (0)
- Kutane CD 56 positive NK-Zell-Lymphome (2003) (0)
- OP0218 CENTRAL NERVOUS SYSTEM PAIN RESPONSE AND COMPONENTS OF DISEASE ACTIVITY IN RA PATIENTS AFTER TREATMENT WITH CERTOLIZUMAB OR PLACEBO: A POST-HOC ANALYSIS FROM THE PRECEPRA TRIAL (2020) (0)
- Introduction: B cell-mediated autoimmune diseases (2014) (0)
- 07 Plasma-cell directed therapies (2020) (0)
- 2.1 Zyanose (2013) (0)
- 4.5 Morbus Whipple (Lipodystrophia intestinalis) (2013) (0)
- Promotor Methylation in Gastric Cancer – A Functional Trigger of Intestinal Differentiation Under Special Consideration of CDX1 Expression and NfκB Signalling (2011) (0)
- B cell depletion by Rituximab severely reduces immunoglobulin levels in patients with ANCA-associated vasculitis previously treated with cyclophosphamide (2011) (0)
- 5.1 Akute Tracheobronchitis (2013) (0)
- Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases (2023) (0)
- THU0341 FLT3 ligand concentrations are elevated in anca-associated vasculitides (AAV) and are influenced by immunosuppressive therapy (2017) (0)
- 11.7 Meningitis Meningitis (2015) (0)
- 5.2 Leitsymptom: Splenomegalie (2013) (0)
- 3.1 Transplantation (2013) (0)
- 13.3 Schock (2013) (0)
- New aspects of the etiopathogenesis of systemic lupus erythematosus (2003) (0)
- Immune complex solubility and size govern individual Fc-gamma receptor 1 responses : Novel biomarkers for autoimmune diseases 2 (2021) (0)
- SAT0050 PREDICTION OF RESPONSE TO CERTOLIZUMAB PEGOL TREATMENT BY FUNCTIONAL MRI OF THE BRAIN: AN INTERNATIONAL, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (PRECEPRA) (2020) (0)
- AB0388 IMPROVEMENT OF PATIENT-REPORTED OUTCOMES IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME UNDERGOING CPAP-TREATMENT (2020) (0)
- 4.16 Listeriose (2013) (0)
- 9.1 Definition (2013) (0)
- 5.3 Lungenemphysem (2013) (0)
- 4.15 Leptospirosen (2013) (0)
- OP0117 LONGITUDINAL CHANGE IN THE CENTRAL NERVOUS SYSTEM PAIN RESPONSE AFTER TREATMENT WITH CERTOLIZUMAB OR PLACEBO. A POST-HOC ANALYSIS FROM THE PRECEPRA TRIAL (2020) (0)
- 5.1 Definition (2007) (0)
- [German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic]. (2021) (0)
- JAK inhibitors differentially modulate B cell activation, maturation and function: A comparative analysis of five JAK inhibitors in an in-vitro B cell differentiation model and in patients with rheumatoid arthritis (2023) (0)
- 2.5 Hiatushernie (2013) (0)
- Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus (2022) (0)
- 5.4 Enterokolitiden (2013) (0)
- Das Sjögren-Syndrom (2017) (0)
- AB0682 FUNCTIONAL IMPAIRMENT IN PATIENTS WITH AXIAL SPONDYLOARTHROPATHY IN A GERMAN COHORT: WORSE OUTCOMES AND WORSE QUALITY OF LIFE FOR FEMALE PATIENTS (2020) (0)
- 2.2 Dyspnoe (2013) (0)
- FRI0339 B cell repopulation kinetics after rituximab treatment in anca-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients (2017) (0)
- 2.2 Spondyloarthritiden (SpA) (2013) (0)
- HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis (IBM) (2014) (0)
- [Macrocytic anemia and polychondritis: VEXAS syndrome]. (2023) (0)
- 4.4 Glutensensitive Enteropathie (2013) (0)
- Chinese-European SLE GWAS meta-analysis findings include ten 1 new loci and a genetic basis for increased non-European 2 prevalence 3 (2016) (0)
- 10.5 Kyphoskoliose (2013) (0)
- 23.3 Kollagenosen (2011) (0)
- Innate vs acquired immunity (2013) (0)
- 27.5 Hypothyreose (2011) (0)
- Lymphoid stromal cells - potential implications for the pathogenesis of CVID (2023) (0)
- 13.1 Akutes Abdomen (2007) (0)
- The role of cholesterol in TCR signalling in autoimmune diseases (2021) (0)
- 5.3 Pathogenese (2013) (0)
- Respiratory tract infections and risk factors for infection in a cohort of 330 patients with axial spondyloarthritis or psoriatic arthritis (2022) (0)
- Immundefektsyndrome (2013) (0)
- 4.6 Brucellosen (2013) (0)
- THU0321 Alterations in the peripheral b cell compartment in patients with eosinophilic granulomatosis with polyangiitis (churg-strauss syndrome) (2017) (0)
- FRI0502 SEASONAL CLUSTERING OF ACUTE SARCOIDOSIS IN GERMANY AND ASSOCIATIONS WITH AIR POLLUTION (2020) (0)
- Subject Index Vol. 78, 2008 (2009) (0)
- Favourable outcome of acute hepatitis E infection in patients with ANCA-associated vasculitis (2022) (0)
- 9.4 Pathogenese (2013) (0)
- 1.3 Leitsymptome (2013) (0)
- P134 A preclinical double-blinded, randomized, controlled, multicenter trial (pRCT) on Jak1/Jak2 inhibition in lupus nephritis (2020) (0)
- AB0757 Persistent crp elevation is associated with high morbidity in systemic sclerosis (2018) (0)
- IMMUNOSUPPRESSIVE TREATMENT FOR AUTOIMMUNITY, LYMPHOPROLIFERATION AND GRANULOMATOUS COMPLICATIONS IN PATIENTS WITH CVID (2012) (0)
- 7.2 Akute Appendizitis (2013) (0)
- 4.3 Hyperventilation (2013) (0)
- 11.2 Aortenstenose (2013) (0)
- Contents Vol. 78, 2008 (2009) (0)
- 34346 Pooled safety analysis of respiratory tract infections, including COVID-19, in psoriasis patients treated with secukinumab (2022) (0)
- 11.9 Pulmonalstenose (2013) (0)
- 4.4 Bartonellose (2013) (0)
- THU0053 CONTRIBUTION OF DEFECTIVE NON-APOPTOTIC FAS SIGNALING TO IMMUNE DYSREGULATION IN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS) (2020) (0)
- 11.2 Nierentransplantation (NTX) (2013) (0)
- Analysis of Hand Joint Space Morphology in Women and Men with Hereditary Hemochromatosis (2023) (0)
- THU0105 Prediction of response to CERTOLIZUMAB-PEGOL in rheumatoid arthritis (PRECEPRA) by functional MRI of the brain – an interim analysis of an ongoing investigator initiated phase III trial (2017) (0)
- AB0701 ANTIBODY RAPID TEST POSITIVE HEALTH CARE WORKERS AT A GERMAN UNIVERSITY HOSPITAL: FIRST WAVE CHARACTERISTICS (2021) (0)
- 6.2 Aspergillose (2013) (0)
- lupus erythematosus clinical manifestations of refractory systemic depletes plasma cells and ameliorates The proteasome inhibitior bortezomib and (2015) (0)
- 4.9 Cholera (2013) (0)
- Experimental pathology - 1 (2009) (0)
- Role of apoptosis failure in etiopathogenesis of systemic lupus erythematosus and murine lupus (2008) (0)
- 4.3 Myeloproliferative Neoplasien (MPN) (2013) (0)
- [Visual evoked potentials in 8-year-old children. Normal values and applications in pediatric neurology]. (1984) (0)
- A method for immunomodulation (1995) (0)
- 9.3 Transplantation Transplantation Organtransplantation (2015) (0)
- 11.5 Mitralstenose (2013) (0)
- 2.5 Ödeme (2013) (0)
- 1.1 Definition (2013) (0)
- 10.5 Arthritiden Arthritiden (2015) (0)
- 4.1 Definition (2013) (0)
- 4.3 Leitsymptom (2013) (0)
- 1.11 Leberzirrhose (2013) (0)
- 4.1 Leitsymptome (2015) (0)
- 10.2 Leitsymptome (2015) (0)
- Arthritis Inflammation and Tissue Damage in 12/15-Lipoxygenase Counteracts (2009) (0)
- 2.4 Cholestase (2013) (0)
- 7.10 Kardiopulmonale Reanimation (2013) (0)
- 1.5 Geriatrische Rehabilitation (2013) (0)
- Inflammatory arthritis in systemic sclerosis is associated with elevated C-reactive protein and requires musculoskeletal ultrasound for reliable detection (2023) (0)
- 4.8 Adrenogenitales Syndrom (AGS) (2013) (0)
- 5.6 Transplantation Transplantation (2015) (0)
- [Principles of the diagnostics of inborn errors of immunity]. (2023) (0)
- 7.3 Ileus (2013) (0)
- 6.2 Transfusionstherapie (2013) (0)
- Correlation of mucin production with sensitivity to bortezomib and gemcitabine in pancreatic cancer cells. (2010) (0)
- 6.2 Phlebothrombose (2013) (0)
- 9.1 Pneumothorax (2013) (0)
- FO055THE EFFECT OF B CELL TARGETED THERAPIES ON AUTOANTIBODIES AND EXCESSIVE NEUTROPHIL EXTRACELLULAR TRAP FORMATION IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS (2018) (0)
- 3.3 Lymphadenopathie (2013) (0)
- FcγR responses to soluble immune complexes of varying size: A scalable cell-based reporter system (2020) (0)
- Impact of dietary vitamin D on immunoregulation and disease pathology in lupus-prone NZB/W F1 mice (2022) (0)
- Acute Sarcoidosis Clusters in Cold Season and Is Associated with Ambient Air Pollution: A Retrospective Clinical-Meteorological Study. (2021) (0)
- Editorial: The Role of Nuclear Molecules in the Pathogenesis of Autoimmune Disease (2021) (0)
- 7.2 Akute interstitielle Nephritis (AIN) (2013) (0)
- THU0103 Therapeutical targeting of antigen-induced arthritis with liposomal secretory leukocyte protease inhibitor (antileukoproteinase) (2001) (0)
- Symposium: HMGB1 in Inflammation and Innate Immunity (2011) (0)
- SAT0348 CLINICAL SPECTRUM TIME COURSE OF ANTISYNTHETASE SYNDROME PATIENTS POSITIVE FOR ANTICENTROMERE ANTIBODIES (2020) (0)
- 2.7 Obstipation (2013) (0)
- THU0030 DISTINCT EFFECTS OF FIVE JAK INHIBITORS IN THE MODULATION OF HUMAN B CELL ACTIVATION (2020) (0)
- 6.3 Thrombophlebitis (2013) (0)
- Activation of NF-jB promotes the transition of large, CD43 pre-B cells to small, CD43 pre-B cells (2005) (0)
- 5.6 Prognose (2013) (0)
- Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency (2016) (0)
- Proteasome Inhibitor Bortezomib T-Independent Type 2 Response Resists the The Early Marginal Zone B Cell-Initiated (2010) (0)
- THU0366 SYSTEMATIC CORONARY RISK EVALUATION (SCORE) MISCLASSIFIES CARDIOVASCULAR RISK IN ANTISYNTHETASE SYNDROME: RESULTS OF THE PILOT MULTICENTRIC STUDY RI.CAR.D.A. (2020) (0)
- 11.2 Leitsymptome (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Reinhard Edmund Voll?
Reinhard Edmund Voll is affiliated with the following schools: